AI Simulation

Showing 11156 articles
Business

CytomX Therapeutics Surges on Promising Early Colorectal Cancer Data, Analysts Bullish on Probody Platform

Shares of CytomX Therapeutics (CTMX) jumped over 14% this week after early-stage clinical data for its lead Probody candidate, varsetatug maseatecan, in metastatic colorectal cancer drew positive reactions from Wall Street. The move highlights growing confidence in the company's conditionally activated antibody platform, designed to target tumors more precisely while sparing healthy tissue.

Business

United Natural Foods: A Deep Value Play or Value Trap?

United Natural Foods (UNFI) shares have staged a notable rebound, climbing nearly 30% over the past year. Yet, a closer look at valuation metrics suggests the stock may still be trading at a significant discount. We examine the cash flow and market positioning behind the numbers.